The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Updated efficacy and safety of SHR-1501, an IL-15RaFc superagonist, with or without Bacille Calmette Guerin (BCG) for high-risk non-muscle invasive bladder cancer (NMIBC): A phase 1/2 study.
 
Zhisong He
No Relationships to Disclose
 
Yuke Chen
No Relationships to Disclose
 
Wei Xue
No Relationships to Disclose
 
Lianhua Zhang
No Relationships to Disclose
 
Jianming Guo
No Relationships to Disclose
 
Hailong Hu
No Relationships to Disclose
 
Shan Liang
No Relationships to Disclose
 
Haitao Niu
No Relationships to Disclose
 
Yu Cao
No Relationships to Disclose
 
Xiang Wang
No Relationships to Disclose
 
Hongqian Guo
No Relationships to Disclose
 
Danfeng Xu
No Relationships to Disclose
 
Xin Xie
No Relationships to Disclose
 
Zengjun Wang
No Relationships to Disclose
 
Hang Huang
No Relationships to Disclose
 
Lei Li
No Relationships to Disclose
 
Xianfeng Zhou
Employment - Jiangsu Hengrui Pharmaceuticals
 
Jiaqin Lin
Employment - Jiangsu Hengrui Pharmaceuticals
 
Xiaojian Xu
Employment - Jiangsu Hengrui Pharmaceuticals
 
Wenliang Wang
Employment - Jiangsu Hengrui Pharmaceuticals